Arianna Gonelli

Ferrara, 44121, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Enhanced Anti-Melanoma Activity of Nutlin-3a Delivered via Ethosomes: Targeting p53-Mediated Apoptosis in HT144 Cells.

Enhanced Anti-Melanoma Activity of Nutlin-3a Delivered via Ethosomes: Targeting p53-Mediated Apoptosis in HT144 Cells.

Journal: Cells

Published: September 06, 2024

Emerging Mechanisms of Physical Exercise Benefits in Adjuvant and Neoadjuvant Cancer Immunotherapy.

Emerging Mechanisms of Physical Exercise Benefits in Adjuvant and Neoadjuvant Cancer Immunotherapy.

Journal: Biomedicines

Published: July 22, 2024

Characterization Methods for Nanoparticle-Skin Interactions: An Overview.

Characterization Methods for Nanoparticle-Skin Interactions: An Overview.

Journal: Life (Basel, Switzerland)

Published: March 29, 2024

Classical and Innovative Evidence for Therapeutic Strategies in Retinal Dysfunctions.

Classical and Innovative Evidence for Therapeutic Strategies in Retinal Dysfunctions.

Journal: International journal of molecular sciences

Published: December 29, 2023

Retinal Alterations Predict Early Prodromal Signs of Neurodegenerative Disease.

Retinal Alterations Predict Early Prodromal Signs of Neurodegenerative Disease.

Journal: International journal of molecular sciences

Published: December 21, 2023

Mitochondria-Targeted Antioxidants, an Innovative Class of Antioxidant Compounds for Neurodegenerative Diseases: Perspectives and Limitations.

Mitochondria-Targeted Antioxidants, an Innovative Class of Antioxidant Compounds for Neurodegenerative Diseases: Perspectives and Limitations.

Journal: International journal of molecular sciences

Published: December 30, 2022

Retraction Notice to: miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation.

Retraction Notice to: miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation.

Journal: Cancer cell

Published: October 28, 2022

New Applications of JAK/STAT Inhibitors in Pediatrics: Current Use of Ruxolitinib.

New Applications of JAK/STAT Inhibitors in Pediatrics: Current Use of Ruxolitinib.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: February 01, 2022

The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus.

The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus.

Journal: Frontiers in immunology

Published: June 15, 2020

Sex/Gender-Specific Imbalance in CVD: Could Physical Activity Help to Improve Clinical Outcome Targeting CVD Molecular Mechanisms in Women?

Sex/Gender-Specific Imbalance in CVD: Could Physical Activity Help to Improve Clinical Outcome Targeting CVD Molecular Mechanisms in Women?

Journal: International journal of molecular sciences

Published: January 16, 2020

Inherited genetic predispositions in F13A1 and F13B genes predict abdominal adhesion formation: identification of gender prognostic indicators.

Inherited genetic predispositions in F13A1 and F13B genes predict abdominal adhesion formation: identification of gender prognostic indicators.

Journal: Scientific reports

Published: July 30, 2018

Effects of Hypoxia and Bed Rest on Markers of Cardiometabolic Risk: Compensatory Changes in Circulating TRAIL and Glutathione Redox Capacity.

Effects of Hypoxia and Bed Rest on Markers of Cardiometabolic Risk: Compensatory Changes in Circulating TRAIL and Glutathione Redox Capacity.

Journal: Frontiers in physiology

Published: April 19, 2018

Showing 1-12 of 21

Last Updated: 09/26/2026